Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial
ContributorsGenevay, Stéphane
Published inAnnals of the rheumatic diseases, vol. 71, no. 4, p. 560-562
Publication date2012
Abstract
Keywords
- Acute Disease
- Adult
- Anti-Inflammatory Agents/administration & dosage/therapeutic use
- Antibodies, Monoclonal, Humanized/administration & dosage/therapeutic use
- Back Pain/etiology
- Diskectomy
- Double-Blind Method
- Female
- Follow-Up Studies
- Humans
- Injections, Subcutaneous
- Kaplan-Meier Estimate
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Sciatica/complications/drug therapy/surgery
- Treatment Outcome
- Tumor Necrosis Factor-alpha/antagonists & inhibitors
Research groups
Citation (ISO format)
GENEVAY, Stéphane et al. Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial. In: Annals of the rheumatic diseases, 2012, vol. 71, n° 4, p. 560–562. doi: 10.1136/annrheumdis-2011-200373
Main files (1)
Article (Published version)
Identifiers
- PID : unige:32498
- DOI : 10.1136/annrheumdis-2011-200373
- PMID : 21998121
Journal ISSN0003-4967
